GETI-B.ST
GETI-B.ST
SE0000202624
Getinge AB ser. B
Loading chart...

Company Profile

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Related stocks

SECT-B.ST
SECT-B.ST • Sweden
SECTRA AB ser B
310.2 SEK
5.98B USD 1Y -1.9%
EKTA-B.ST
EKTA-B.ST • Sweden
Elekta AB ser. B
54.45 SEK
2.08B USD 1Y +8%
LIVN
LIVN • United Kingdom
LivaNova PLC
76.39 USD
4.21B USD 1Y +42.2%
NOLA-B.ST
NOLA-B.ST • Sweden
Nolato AB ser. B
57.1 SEK
1.54B USD 1Y -6.9%
DEMANT.CO
DEMANT.CO • Denmark
Demant A/S
341.2 DKK
10.78B USD 1Y +38.3%
SNN
SNN • United Kingdom
Smith & Nephew SNATS, Inc.
27.24 USD
11.4B USD 1Y -25%
SN.L
SN.L • United Kingdom
SMITH & NEPHEW PLC ORD USD0.20
1,020.5 GBp
11.3B USD 1Y -25.3%
MOVE.SW
MOVE.SW • Switzerland
MEDACTA GROUP N
114.2 CHF
2.74B USD 1Y -25.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.4% p.a.
Max Drawdown (5Y)
-61.5%
Sharpe Ratio (5Y)
-0.27
Beta Factor
0.82
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -61.5% in the extended horizon.
ende